Menveo 1 vial-a-c-y-w-135-DIP 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FQP3E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,806
Award facts
- Contract value 100% obligated
- $29,806.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Menveo (1 vial-A-C-Y-W-135-DIP 0.5mL), a meningococcal vaccine product. This firm fixed price delivery order has a ceiling value of $29,806.25 and is scheduled for completion by November 5, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply an extensive range of medications, vaccines, and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, maintains a substantial portfolio of delivery orders with the Defense Logistics Agency covering diverse pharmaceutical products and medical commodities. The company's federal contracts consistently reflect competitively awarded, firm fixed price arrangements supporting military and veteran healthcare systems, the Defense Health Agency, and other government healthcare entities. The DLA Troop Support Medical is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen among the key federal pharmaceutical supply partners.
Quick answers
Who was awarded contract SPE2DR26FQP3E?
SPE2DR26FQP3E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DR26FQP3E worth?
The government has obligated $29,806 on SPE2DR26FQP3E.
Is contract SPE2DR26FQP3E an order under another contract?
Yes. SPE2DR26FQP3E is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQP3E competed?
The extent of competition for SPE2DR26FQP3E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award